Search details
1.
De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR-): survival outcomes from a multicentre, open-label, randomised, phase 2 trial.
Lancet Oncol
; 23(5): 625-635, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35405088
2.
Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist's Decision on Systemic Therapy in a Real-World Setting.
Int J Mol Sci
; 23(15)2022 Aug 05.
Article
in English
| MEDLINE | ID: mdl-35955851
3.
Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple-negative early breast cancer: Primary translational analysis of the WSG-ADAPT-TN trial.
Int J Cancer
; 146(1): 262-271, 2020 01 01.
Article
in English
| MEDLINE | ID: mdl-31162838
4.
BRCA1-like profile predicts benefit of tandem high dose epirubicin-cyclophospamide-thiotepa in high risk breast cancer patients randomized in the WSG-AM01 trial.
Int J Cancer
; 139(4): 882-9, 2016 Aug 15.
Article
in English
| MEDLINE | ID: mdl-26946057
5.
Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial.
Breast Cancer Res Treat
; 150(2): 279-88, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-25721604
6.
Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR- Trial.
Clin Cancer Res
; 29(4): 805-814, 2023 02 16.
Article
in English
| MEDLINE | ID: mdl-36441798
7.
De-escalated Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer (TNBC): Impact of Molecular Markers and Final Survival Analysis of the WSG-ADAPT-TN Trial.
Clin Cancer Res
; 28(22): 4995-5003, 2022 11 14.
Article
in English
| MEDLINE | ID: mdl-35797219
8.
Inter-observer agreement for the histological diagnosis of invasive lobular breast carcinoma.
J Pathol Clin Res
; 8(2): 191-205, 2022 03.
Article
in English
| MEDLINE | ID: mdl-34889530
9.
Phenotype Discordance between Primary Tumor and Metastasis Impacts Metastasis Site and Outcome: Results of WSG-DETECT-PriMet.
Breast Care (Basel)
; 16(5): 475-483, 2021 Oct.
Article
in English
| MEDLINE | ID: mdl-34720807
10.
Granulomatous Mastitis: A Therapeutic and Diagnostic Challenge.
Breast Care (Basel)
; 13(6): 413-418, 2018 Dec.
Article
in English
| MEDLINE | ID: mdl-30800035
11.
Subclonal analysis in a lobular breast cancer with classical and solid growth pattern mimicking a solid-papillary carcinoma.
J Pathol Clin Res
; 3(3): 191-202, 2017 Jul.
Article
in English
| MEDLINE | ID: mdl-28770103
Results
1 -
11
de 11
1
Next >
>>